Evidence map›Paper›PMID 32005763›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2020

SIRT1 Decreases Emotional Pain Vulnerability with Associated CaMKIIα Deacetylation in Central Amygdala.

Chenghua Zhou, Yuqing Wu, Xiaobao Ding, Naihao Shi, Youqin Cai, Zhizhong Z Pan

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07403929 (Determination of the Effect of Fermented Grape Juice Consumption on Oxidative Stress and Inflammation Biomarkers and SIRT-1 Levels in Fibromyalgia Patients), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07403929 narecruitingnot on this mapstarted 2026, after this paper: background citation

Determination of the Effect of Fermented Grape Juice Consumption on Oxidative Stress and Inflammation Biomarkers and SIRT-1 Levels in Fibromyalgia Patients

TypeinterventionalSponsorHacettepe UniversityRan2026 to 2027Enrolled45ConditionsFibromyalgia, Fibromyalgia (FM), Fibromyalgia Syndrome, PrimaryArmsMedical Nutrition Therapy (MNT), Hardaliye (200 mL/day)
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Pathology of pain and its implications for therapeutic interventions.Signal transduction and targeted therapy · 2024
    Review
  10. The Epigenetics of Neuropathic Pain: A Systematic Update.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. SIRT1: A promising therapeutic target for chronic pain.CNS neuroscience & therapeutics · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Chenghua ZhouDepartment of Anesthesiology and Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.
Yuqing WuJiangsu Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou 266061, People's Republic of China.
Xiaobao DingJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, and.
Naihao ShiJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, and.
Youqin CaiDepartment of Anesthesiology and Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.
Zhizhong Z PanDepartment of Anesthesiology and Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, zzpan@mdanderson.org.ORCID 0000-0002-4022-8750
Centre for Drug Research and Development · CAThe University of Texas MD Anderson Cancer Center · USXuzhou Medical College · CN

Funding

Dnmt3a as an epigenetic target for chronic pain treatmentRF1NS113256 · NINDS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI PAN, ZHIZHONG Z. · 2019 to 2019
$2.7M
Epigenetic basis for pain vulnerabilityR01DE025943 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI PAN, ZHIZHONG Z. · 2016 to 2019
$1.6M
NIDCR NIH HHS R01 DE025943NINDS NIH HHS RF1 NS113256
6 · The paper itself

Abstract

Emotional disorders are common comorbid conditions that further exacerbate the severity and chronicity of chronic pain. However, individuals show considerable vulnerability to the development of chronic pain under similar pain conditions. In this study on male rat and mouse models of chronic neuropathic pain, we identify the histone deacetylase Sirtuin 1 (SIRT1) in central amygdala as a key epigenetic regulator that controls the development of comorbid emotional disorders underlying the individual vulnerability to chronic pain. We found that animals that were vulnerable to developing behaviors of anxiety and depression under the pain condition displayed reduced SIRT1 protein levels in central amygdala, but not those animals resistant to the emotional disorders. Viral overexpression of local SIRT1 reversed this vulnerability, but viral knockdown of local SIRT1 mimicked the pain effect, eliciting the pain vulnerability in pain-free animals. The SIRT1 action was associated with CaMKIIα downregulation and deacetylation of histone H3 lysine 9 at the

Indexed as

Psychological DistressAcetylationAnimalsAnxietyCalcium-Calmodulin-Dependent Protein Kinase Type 2Central Amygdaloid NucleusChronic PainDepressionDisease SusceptibilityDown-RegulationExploratory BehaviorGABAergic NeuronsGenetic VectorsHistonesHyperalgesiaMaleCalcium-Calmodulin-Dependent Protein Kinase Type 2Camk2a protein, mouseCamk2a protein, ratHistonesSirt1 protein, mouseSirt1 protein, ratSirtuin 1CaMKIIαcentral amygdalachronic painpain vulnerabilitySIRT1

Identifiers

PMID32005763
PMCPMC7083291
OpenAlexW3003338215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.